Official Achievement Announcement

Our newly developed medical‑grade composite‑material laparoscopic trocar has officially obtained the medical device registration certificate. Adopting an innovative titanium alloy‑polymer composite structure, the product breaks through the performance limitations of single‑material designs and achieves an optimal balance between mechanical strength and biocompatibility. Tests verify that the new trocar delivers a flexural strength of 850 MPa with an elastic modulus matching that of human bone. While retaining the durability of stainless‑steel instruments, it achieves a 35% weight reduction, offering an improved ergonomic solution for long‑duration laparoscopic surgeries.

R&D Background & Pain Points

Traditional laparoscopic trocars face three‑fold dilemmas in material selection. Stainless steel features high density (7.9 g/cm³), increasing operational fatigue for surgeons. Pure titanium incurs high costs and poses machining difficulties. Medical‑grade polymers lack sufficient strength and are prone to creep deformation.

Clinical studies show that during laparoscopic surgeries lasting over 3 hours, fatigue accumulation caused by instrument weight increases surgeons' hand tremor amplitude by 47%, directly compromising manipulation precision. In addition, metal materials generate imaging artifacts in CT/MRI scans, interfering with intraoperative navigation.

Core Technological Innovations

1. Gradient Composite Material TechnologyA metal‑polymer gradient composite structure is developed. The outer layer of the trocar is made of medical‑grade PEEK (polyetheretherketone), providing excellent biocompatibility and radiolucency. The inner layer is micro‑arc‑oxidized titanium alloy to ensure wear resistance of the instrument channel. Molecular‑level interfacial bonding technology achieves an interfacial bonding strength of 45 MPa between the two materials.
2. Nanocrystalline Structure Regulation ProcessA combined process of equal‑channel angular pressing and low‑temperature annealing refines titanium alloy grain sizes to below 150 nm. The nanocrystalline structure raises the yield strength to 1100 MPa while boosting the fatigue limit by 2.3‑fold and extending service life.
3. Functional Surface Coating TechnologyA silver‑loaded hydroxyapatite composite coating is developed, forming a 2–5 μm functional layer via magnetron sputtering. Featuring sustained‑release antibacterial properties (＞99% bacteriostatic rate against Staphylococcus aureus), the coating also promotes healing at the tissue‑implant interface.

Working Mechanism

The advantages of the composite trocar originate from multi‑scale synergistic effects. At the microscale, the nanocrystalline structure strengthens the material via the Hall‑Petch effect, while fine grains hinder crack propagation. At the mesoscale, the gradient design enables stress buffering with elastic modulus varying gradually from the outer layer to the inner layer (3 GPa → 110 GPa), matching the biomechanical properties of abdominal wall tissues. At the macroscale, the lightweight design reduces the instrument's moment of inertia and improves manipulation responsiveness. Through an ion‑exchange mechanism, the functional coating continuously releases silver ions (0.1–0.5 μg/cm²·day), forming an antibacterial microenvironment on the instrument surface.

Performance Validation

In‑vitro experiments show the new trocar achieves Grade 0 cytotoxicity (per ISO 10993‑5) with no sensitization reactions. Under simulated surgical conditions, after 200 000 instrument insertion‑withdrawal cycles, the inner‑diameter wear loss of the composite trocar is only 8 μm, far lower than the 25 μm measured for stainless‑steel trocars.

Clinical trial data reveals that surgeries using the new trocar yield an average postoperative Day‑1 pain score (VAS) of 3.2, 1.8 points lower than the control group, with incision healing time shortened by 1.5 days. Imaging assessments demonstrate a 78% reduction in artifact area of the composite material in CT scans, with full MRI compatibility achieved.

R&D Strategy & Philosophy

We adhere to the R&D philosophy: Performance is defined by materials, functions are determined by structures, and build a three‑dimensional innovation system. Vertically, we optimize intrinsic material properties at the atomic‑arrangement level. Horizontally, we realize functional integration via multi‑material combinations. Temporally, we study the full‑period behavioral evolution of materials both in‑vivo and ex‑vivo.

We have established the world's first material database for laparoscopic instruments, containing 368 performance parameters of 127 materials, providing data support for personalized instrument development.

Future Outlook

Over the next five years, materials for laparoscopic trocars will develop in four directions: first, 4D‑printed smart materials whose physical properties adjust with body temperature and pH values; second, biomimetic materials mimicking the viscoelasticity of peritoneal tissues; third, monitoring materials integrated with fiber‑optic sensors to measure real‑time tissue pressure; fourth, eco‑friendly materials including bioabsorbable trocars based on polyhydroxyalkanoate (PHA).

Our under‑development sensory trocar will enter pre‑clinical studies in 2027. Capable of indicating tissue injury risks via color changes, the product delivers visual early warnings for surgical safety.